Skip to content

Total at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$157.51M
BioLife Solutions logo
BioLife SolutionsBLFS
$88.79M+118%
KDK
Kodiak AI, Inc. Common StockKDK
$25.24M
Absci Corporation logo
Absci CorporationABSI
$122.78M+41.1%
Hagerty logo
HagertyHGTY
$73.56M-21.3%
GitLab logo
GitLabGTLB
$619.16M-1.8%

Other financials

Income statement

See full
Revenue$171.1M+0.5%
Gross profit$64.8M+6.3%
Operating income$9.0M+160%
Net income$9.3M+181%
EPS (diluted)$0.47+176%

Balance sheet

See full
Cash & equivalents$28.1M-17.4%
Total debt$145.0M+9.4%
Total equity$166.7M+1.1%
Total assets$439.2M-0.4%

Cash flow

See full
Operating cash flow$8.0M+108%
CapEx$1.1M+4.7%
Free cash flow$7.0M+145%

Valuation

See full
Market cap$64.67M+22.3%
Enterprise value$181.61M+19.9%
P/E710.6×
P/S0.1×0.0×

Profitability

See full
Gross margin34.5%+1.9pp
Operating margin-1.1%-0.5pp
Net margin0%0.0pp
FCF margin-0.2%-0.1pp

Returns & leverage

See full
Return on equity0.1%0.0pp
Debt / equity0.9×+0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Cato Corporation in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Cato Corporation’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cato Corporation's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cato Corporation's total?
Cato Corporation (CATO) reported total of $56.59M in Q4 2025.
How has Cato Corporation's total changed year-over-year?
Cato Corporation's total decreased by 1.2% year-over-year, from $57.27M to $56.59M.
What is the long-term trend for Cato Corporation's total?
Over 4 years (2021 to 2025), Cato Corporation's total has grown at a -21.2% compound annual growth rate (CAGR), from $146.91M to $56.59M.